ES2990204T3 - Procedimientos de aislamiento y utilización de la membrana de Descemet y composiciones que incluyen membrana de Descemet aislada - Google Patents
Procedimientos de aislamiento y utilización de la membrana de Descemet y composiciones que incluyen membrana de Descemet aislada Download PDFInfo
- Publication number
- ES2990204T3 ES2990204T3 ES19809212T ES19809212T ES2990204T3 ES 2990204 T3 ES2990204 T3 ES 2990204T3 ES 19809212 T ES19809212 T ES 19809212T ES 19809212 T ES19809212 T ES 19809212T ES 2990204 T3 ES2990204 T3 ES 2990204T3
- Authority
- ES
- Spain
- Prior art keywords
- membrane
- descemet
- isolated
- limbal
- limbal stem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000002555 descemet membrane Anatomy 0.000 title claims abstract description 274
- 238000000034 method Methods 0.000 title claims abstract description 72
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- 206010072138 Limbal stem cell deficiency Diseases 0.000 claims abstract description 12
- 210000000130 stem cell Anatomy 0.000 claims description 143
- 210000004087 cornea Anatomy 0.000 claims description 101
- 210000003683 corneal stroma Anatomy 0.000 claims description 21
- 238000004113 cell culture Methods 0.000 claims description 15
- 230000012010 growth Effects 0.000 claims description 14
- 239000006143 cell culture medium Substances 0.000 claims description 13
- 239000012530 fluid Substances 0.000 claims description 11
- 230000010261 cell growth Effects 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 7
- 208000014674 injury Diseases 0.000 claims description 7
- 230000008733 trauma Effects 0.000 claims description 7
- 210000003038 endothelium Anatomy 0.000 claims description 6
- 206010064996 Ulcerative keratitis Diseases 0.000 claims description 5
- 230000035755 proliferation Effects 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 201000007717 corneal ulcer Diseases 0.000 claims description 4
- 230000003628 erosive effect Effects 0.000 claims description 4
- 238000000338 in vitro Methods 0.000 claims description 4
- 208000023715 Ocular surface disease Diseases 0.000 claims description 2
- 238000005138 cryopreservation Methods 0.000 claims description 2
- 230000007547 defect Effects 0.000 claims description 2
- 230000002255 enzymatic effect Effects 0.000 claims description 2
- 238000007710 freezing Methods 0.000 claims description 2
- 230000008014 freezing Effects 0.000 claims description 2
- 230000002085 persistent effect Effects 0.000 claims description 2
- 230000000306 recurrent effect Effects 0.000 claims description 2
- 230000004927 fusion Effects 0.000 claims 2
- 238000004108 freeze drying Methods 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 abstract description 30
- 210000004027 cell Anatomy 0.000 description 29
- 210000001691 amnion Anatomy 0.000 description 27
- 102000013013 Member 2 Subfamily G ATP Binding Cassette Transporter Human genes 0.000 description 16
- 108010090306 Member 2 Subfamily G ATP Binding Cassette Transporter Proteins 0.000 description 16
- 239000000758 substrate Substances 0.000 description 15
- 239000001963 growth medium Substances 0.000 description 14
- 102000029816 Collagenase Human genes 0.000 description 11
- 108060005980 Collagenase Proteins 0.000 description 11
- 229960002424 collagenase Drugs 0.000 description 11
- 239000012634 fragment Substances 0.000 description 11
- 239000004033 plastic Substances 0.000 description 11
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 10
- 210000003560 epithelium corneal Anatomy 0.000 description 10
- 239000012091 fetal bovine serum Substances 0.000 description 10
- 239000013589 supplement Substances 0.000 description 10
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 230000007774 longterm Effects 0.000 description 8
- 238000002054 transplantation Methods 0.000 description 8
- 238000003125 immunofluorescent labeling Methods 0.000 description 7
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 210000002919 epithelial cell Anatomy 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 230000001817 pituitary effect Effects 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 210000002889 endothelial cell Anatomy 0.000 description 5
- 238000012744 immunostaining Methods 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 239000006285 cell suspension Substances 0.000 description 4
- 210000000871 endothelium corneal Anatomy 0.000 description 4
- 238000012014 optical coherence tomography Methods 0.000 description 4
- 239000012679 serum free medium Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 230000035899 viability Effects 0.000 description 4
- 208000010412 Glaucoma Diseases 0.000 description 3
- 238000001574 biopsy Methods 0.000 description 3
- BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 3
- 210000003855 cell nucleus Anatomy 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 238000001804 debridement Methods 0.000 description 3
- 210000000981 epithelium Anatomy 0.000 description 3
- 230000036512 infertility Effects 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 208000009299 Benign Mucous Membrane Pemphigoid Diseases 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 2
- 208000009329 Graft vs Host Disease Diseases 0.000 description 2
- 206010042033 Stevens-Johnson syndrome Diseases 0.000 description 2
- 231100000168 Stevens-Johnson syndrome Toxicity 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 210000002469 basement membrane Anatomy 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000002771 cell marker Substances 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 210000000795 conjunctiva Anatomy 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000007515 enzymatic degradation Effects 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 208000024908 graft versus host disease Diseases 0.000 description 2
- 230000000642 iatrogenic effect Effects 0.000 description 2
- 238000003364 immunohistochemistry Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 208000015200 ocular cicatricial pemphigoid Diseases 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- IICCLYANAQEHCI-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 IICCLYANAQEHCI-UHFFFAOYSA-N 0.000 description 1
- 208000009043 Chemical Burns Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010011013 Corneal erosion Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 210000002159 anterior chamber Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 210000000399 corneal endothelial cell Anatomy 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 108010007093 dispase Proteins 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000005081 epithelial layer Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229940124589 immunosuppressive drug Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 206010023365 keratopathy Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 230000000508 neurotrophic effect Effects 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 210000005059 placental tissue Anatomy 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 229930187593 rose bengal Natural products 0.000 description 1
- 229940081623 rose bengal Drugs 0.000 description 1
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000004017 serum-free culture medium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000011476 stem cell transplantation Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000036575 thermal burns Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3675—Nerve tissue, e.g. brain, spinal cord, nerves, dura mater
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F2/142—Cornea, e.g. artificial corneae, keratoprostheses or corneal implants for repair of defective corneal tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3666—Epithelial tissues other than skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
- C12N2533/92—Amnion; Decellularised dermis or mucosa
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Transplantation (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Developmental Biology & Embryology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Vascular Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Virology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862747715P | 2018-10-19 | 2018-10-19 | |
| PCT/US2019/056938 WO2020081934A1 (en) | 2018-10-19 | 2019-10-18 | Methods of isolating and using descemet's membrane and compositions including isolated descemet's membrane |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2990204T3 true ES2990204T3 (es) | 2024-11-29 |
Family
ID=68655628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES19809212T Active ES2990204T3 (es) | 2018-10-19 | 2019-10-18 | Procedimientos de aislamiento y utilización de la membrana de Descemet y composiciones que incluyen membrana de Descemet aislada |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US12383655B2 (de) |
| EP (2) | EP4491716A3 (de) |
| ES (1) | ES2990204T3 (de) |
| WO (1) | WO2020081934A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2990204T3 (es) | 2018-10-19 | 2024-11-29 | Univ Minnesota | Procedimientos de aislamiento y utilización de la membrana de Descemet y composiciones que incluyen membrana de Descemet aislada |
| US12257365B2 (en) | 2019-04-26 | 2025-03-25 | Regents Of The University Of Minnesota | Incised Descemet's membrane and methods of making and using |
| KR102417981B1 (ko) * | 2020-05-21 | 2022-07-05 | 충북대학교 산학협력단 | 각막내피세포 이식용 인공 지지체, 이의 제조방법 및 이를 이용한 초박형 데스메막박리 각막내피층판 이식편 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2648702A1 (fr) | 1989-06-23 | 1990-12-28 | Hanna Khalil | Lentille pour epikeratophakie et keratotome notamment destine a la realisation d'une incision de reception d'une telle lentille |
| US5964748A (en) | 1995-10-20 | 1999-10-12 | Peyman; Gholam A. | Intrastromal corneal modification |
| IL120005A (en) * | 1997-01-14 | 2000-08-31 | Ramot University Authority Of | Pharmaceutical compositions for the treatment of the eye |
| AU2878200A (en) | 1999-02-11 | 2000-08-29 | Schepens Eye Research Institute, Inc., The | Growth medium for human corneal endothelial cells |
| US7347876B2 (en) * | 2001-04-25 | 2008-03-25 | Ray Jui-Fang Tsai | Method for expansion of epithelial stem cells |
| ITRM20010476A1 (it) * | 2001-08-03 | 2003-02-03 | Idi Irccs | Lamine di epitelio corneale umano ricostruite e metodo per il loro ottenimento. |
| US7025791B2 (en) | 2002-12-02 | 2006-04-11 | Gi Dynamics, Inc. | Bariatric sleeve |
| CN1635115A (zh) | 2004-05-27 | 2005-07-06 | 天津医科大学眼科中心 | 人成纤维细胞滋养的人角膜缘干细胞组织工程产品及制备 |
| TWI407967B (zh) | 2006-04-28 | 2013-09-11 | Ray Jui Fang Tsai | 人類角膜內皮幹細胞之擴增方法 |
| JP5552690B2 (ja) | 2006-09-13 | 2014-07-16 | ディーエスエム アイピー アセッツ ビー．ブイ． | 被覆された医療装置 |
| EP2764846A1 (de) | 2007-02-08 | 2014-08-13 | Kaneka Corporation | Injektor für Augen |
| US20110166650A1 (en) | 2008-09-04 | 2011-07-07 | Massimo Busin | New technique for preparing, storing and transplanting endothelial grafts |
| US20100256651A1 (en) | 2009-04-07 | 2010-10-07 | Dharmendra Jani | Intraocular Lens Injector with Hydrophilic Coating |
| US8287890B2 (en) | 2009-12-15 | 2012-10-16 | C.R. Bard, Inc. | Hydrophilic coating |
| US20140155871A1 (en) | 2012-05-10 | 2014-06-05 | James Stuart Cumming | Method for preparing corneal donor tissue for refractive eye surgery utilizing the femtosecond laser |
| US20140171956A1 (en) | 2012-12-17 | 2014-06-19 | Abbott Medical Optics Inc. | Detecting coatings on intraocular lens insertion devices and methods of manufacturing the devices |
| CN107979992B (zh) | 2015-06-08 | 2020-05-22 | 科尔尼特视觉有限公司 | 人工角膜及其用途 |
| US11510931B2 (en) * | 2016-09-28 | 2022-11-29 | Medicon Pharmaceuticals, Inc. | Compositions and methods for treating ophthalmic conditions |
| US10481051B2 (en) | 2016-10-13 | 2019-11-19 | Lions VisionGift | Corneal tissue sample assemblies and related methods of use |
| CN106955372B (zh) * | 2017-04-12 | 2020-08-14 | 山东省眼科研究所 | 一种组织工程角膜内皮的构建方法 |
| ES2990204T3 (es) | 2018-10-19 | 2024-11-29 | Univ Minnesota | Procedimientos de aislamiento y utilización de la membrana de Descemet y composiciones que incluyen membrana de Descemet aislada |
| EP3698758A1 (de) | 2019-02-20 | 2020-08-26 | Leibniz-Institut für Polymerforschung Dresden e.V. | Vorrichtung und anordnungen für ausgerichteten transport, mikroskopische untersuchung und ausgerichtetes ausstossen eines gewebetransplantats oder -implantats |
| US12257365B2 (en) | 2019-04-26 | 2025-03-25 | Regents Of The University Of Minnesota | Incised Descemet's membrane and methods of making and using |
| US12185699B2 (en) | 2019-11-20 | 2025-01-07 | Egg-Chick Automated Technologies | Assembly for transporting and separating living poultry birds |
| WO2022241252A1 (en) | 2021-05-13 | 2022-11-17 | Regents Of The University Of Minnesota | Descemet membrane endothelial keratoplasty (dmek) assemblies and injectors with friction-reducing coatings |
-
2019
- 2019-10-18 ES ES19809212T patent/ES2990204T3/es active Active
- 2019-10-18 WO PCT/US2019/056938 patent/WO2020081934A1/en not_active Ceased
- 2019-10-18 EP EP24195485.8A patent/EP4491716A3/de active Pending
- 2019-10-18 US US17/286,537 patent/US12383655B2/en active Active
- 2019-10-18 EP EP19809212.4A patent/EP3867357B1/de active Active
-
2025
- 2025-07-24 US US19/278,964 patent/US20250345484A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3867357A1 (de) | 2021-08-25 |
| US12383655B2 (en) | 2025-08-12 |
| WO2020081934A1 (en) | 2020-04-23 |
| US20250345484A1 (en) | 2025-11-13 |
| EP4491716A2 (de) | 2025-01-15 |
| EP4491716A3 (de) | 2025-04-02 |
| EP3867357B1 (de) | 2024-09-25 |
| US20210379246A1 (en) | 2021-12-09 |
| EP3867357C0 (de) | 2024-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250345484A1 (en) | Methods of isolating and using descemet's membrane and compositions including isolated descemet's membrane | |
| Nakamura et al. | The successful culture and autologous transplantation of rabbit oral mucosal epithelial cells on amniotic membrane | |
| US7824671B2 (en) | Retinal pigment epithelial cell cultures on amniotic membrane and transplantation | |
| JP4392855B2 (ja) | 角膜上皮様シート、及びその作製方法 | |
| JP5255846B2 (ja) | 生体内で細胞増殖可能な角膜内皮製剤 | |
| KR20050105242A (ko) | 양막-유래 의용재료 및 그 제조방법 | |
| KR20070015519A (ko) | 생체 조직 시트, 그것의 제조 방법, 및 그것을 이용한 이식방법 | |
| Nicolini et al. | The anterior lens capsule used as support material in RPE cell‐transplantation | |
| JP2001161353A (ja) | 移植用細胞片及びその作成方法 | |
| US7611895B2 (en) | Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering | |
| Khadamy | Harnessing the underutilized potential of lens capsule transplantation in ophthalmology: a narrative review of current applications and future directions | |
| KR20070037451A (ko) | 각막 상피 시트 및 그 제조 방법 | |
| KR20070008590A (ko) | 각막 상피 시트, 그의 제조 방법, 및 그를 이용한 이식방법 | |
| CN1255531C (zh) | 冻存自体角膜缘干细胞的无饲养层构建角膜上皮方法 | |
| Kim et al. | The effect of in vivo grown corneal epithelium transplantation on persistent epithelial defects with limbal stem cell deficiency | |
| Niparugs et al. | Ocular surface transplantation and amniotic membrane surgery | |
| Sharma et al. | Limbal stem cell transplants and amniotic membrane grafts in ocular surface disease: current perspectives. | |
| Sangwan | Cultivated Limbal Stem Cell Transplantation—The Surgical Technique | |
| Dekaris et al. | Cultivated Limbal Epithelial Stem Cell | |
| Javadi et al. | Early results of autologous cultivated limbal stem cell transplantation in total limbal stem cell deficiency | |
| Solomon | Ocular Surface Reconstruction | |
| Kim et al. | 23 Eye Bank Preparation of Endothelial Keratoplasty Grafts | |
| Padmanabahn et al. | plate" can be employed, the spatial resolution may be | |
| Sangwan et al. | Symposium-TRIP |